Colgate-Palmolive (NYSE:CL) Stock Rating Lowered by Wells Fargo & Company

Colgate-Palmolive (NYSE:CL) was downgraded by equities researchers at Wells Fargo & Company from an “equal weight” rating to an “underweight” rating in a research report issued to clients and investors on Monday, MarketBeat reports. They currently have a $100.00 target price on the stock. Wells Fargo & Company‘s price objective indicates a potential downside of 4.39% from the stock’s previous close.

CL has been the topic of a number of other reports. Evercore ISI lifted their price target on Colgate-Palmolive from $100.00 to $106.00 and gave the company an “outperform” rating in a research note on Thursday, July 18th. UBS Group lifted their price target on Colgate-Palmolive from $119.00 to $122.00 and gave the company a “buy” rating in a research note on Wednesday, September 4th. TD Cowen lifted their price target on Colgate-Palmolive from $110.00 to $115.00 and gave the company a “buy” rating in a research note on Tuesday, July 30th. Redburn Atlantic upgraded Colgate-Palmolive to a “hold” rating in a research note on Thursday, August 1st. Finally, Stifel Nicolaus lifted their price objective on Colgate-Palmolive from $95.00 to $105.00 and gave the stock a “buy” rating in a report on Monday, July 22nd. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and thirteen have given a buy rating to the company. According to MarketBeat, Colgate-Palmolive presently has an average rating of “Moderate Buy” and an average target price of $102.79.

Colgate-Palmolive Trading Down 0.8 %

Shares of CL stock opened at $104.59 on Monday. The business’s 50 day moving average is $102.41 and its two-hundred day moving average is $95.55. Colgate-Palmolive has a twelve month low of $67.62 and a twelve month high of $109.30. The company has a market capitalization of $85.81 billion, a P/E ratio of 33.10, a price-to-earnings-growth ratio of 3.72 and a beta of 0.40. The company has a current ratio of 1.06, a quick ratio of 0.70 and a debt-to-equity ratio of 16.90.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, July 26th. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.87 by $0.04. Colgate-Palmolive had a return on equity of 470.19% and a net margin of 14.21%. The company had revenue of $5.06 billion for the quarter, compared to the consensus estimate of $5 billion. During the same period last year, the business posted $0.77 EPS. The company’s revenue was up 4.9% on a year-over-year basis. Equities analysts forecast that Colgate-Palmolive will post 3.57 EPS for the current year.

Insider Transactions at Colgate-Palmolive

In related news, Director Martina Hundmejean sold 2,313 shares of the company’s stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the completion of the transaction, the director now directly owns 11,755 shares in the company, valued at $1,220,874.30. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, Director Martina Hundmejean sold 2,313 shares of the company’s stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the completion of the transaction, the director now directly owns 11,755 shares in the company, valued at $1,220,874.30. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Sally Massey sold 15,850 shares of the company’s stock in a transaction on Tuesday, August 6th. The shares were sold at an average price of $103.28, for a total value of $1,636,988.00. Following the completion of the transaction, the insider now owns 13,942 shares of the company’s stock, valued at $1,439,929.76. The disclosure for this sale can be found here. Insiders sold a total of 43,490 shares of company stock valued at $4,486,063 over the last three months. 0.34% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Colgate-Palmolive

A number of institutional investors have recently added to or reduced their stakes in CL. Vanguard Group Inc. boosted its position in shares of Colgate-Palmolive by 0.5% in the fourth quarter. Vanguard Group Inc. now owns 79,894,344 shares of the company’s stock worth $6,368,378,000 after buying an additional 416,853 shares during the period. Price T Rowe Associates Inc. MD boosted its position in shares of Colgate-Palmolive by 27.8% in the first quarter. Price T Rowe Associates Inc. MD now owns 41,067,130 shares of the company’s stock worth $3,698,096,000 after buying an additional 8,933,912 shares during the period. Massachusetts Financial Services Co. MA boosted its position in shares of Colgate-Palmolive by 40.7% in the second quarter. Massachusetts Financial Services Co. MA now owns 8,969,498 shares of the company’s stock worth $870,400,000 after buying an additional 2,593,313 shares during the period. Legal & General Group Plc boosted its position in shares of Colgate-Palmolive by 0.8% in the second quarter. Legal & General Group Plc now owns 7,785,101 shares of the company’s stock worth $755,465,000 after buying an additional 61,413 shares during the period. Finally, GUARDCAP ASSET MANAGEMENT Ltd boosted its holdings in Colgate-Palmolive by 4.1% in the first quarter. GUARDCAP ASSET MANAGEMENT Ltd now owns 6,987,454 shares of the company’s stock valued at $629,220,000 after purchasing an additional 278,150 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.